Promoter holding
64.27%
AP
Aril Pharma Limited - Due diligence report
A 360° intelligence report on Aril Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress si…
AP
Aril Pharma Limited
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Aril Pharma Limited — 360° Intelligence Report
Generated from MCA filings & public records49/100
Trust Score
Caution Indicated
Aril Pharma Limited is assessed as Caution Indicated with a Trust Score of 49/100. Aril Pharma Limited is a public limited indian non-government company incorporated in 2002, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.
Report generated on 11 Jul 2026 from the latest processed filings. Aril Pharma Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreCaution Indicated
49/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
23/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
No processed financialsFinancial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: N/A No Data
- Financial statements needed for a credit view.
Charges position: 0 open (-) · 3 satisfied (19.00 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| State Bank Of India | 3 | 48.0 cr |
Compliance Score: 23/100 Caution Indicated
- Company status is "Under Liquidation" - not Active.
- Last balance sheet is for Mar 2011 - filings overdue.
- Litigation present in 1 court forum(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VIJAY KUMAR CHOPRA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SATISH SURANA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VAIBHAV PURNANDU JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANUPAMA PURNANDU JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- VIJAY KUMAR CHOPRA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth N/A · Distress 55
Growth signals & trust indicators
Operating for 23+ years.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Under Liquidation.
Compliance score is weak (23/100).
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence40/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- No financials on record - ask for audited statements.
Banker assessment24/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view29/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events24 Jul 2014
Director ceased
SATISH SURANA
01 Oct 2011
Director ceased
YASHWANT SURANA
30 Sep 2011
Last AGM held
Annual general meeting
31 Mar 2011
Latest balance sheet
Filed with ROC
24 Aug 2009
Director appointed
SATISH SURANA (Additional Director)
24 Mar 2009
Director ceased
GIRRAJ MOOLCHAND VIJAYVARGIYA
12 Jan 2009
Director appointed
VIJAY KUMAR CHOPRA (Additional Director)
29 Sep 2008
Director ceased
VAIBHAV PURNANDU JAIN
04 Apr 2008
Director appointed
VAIBHAV PURNANDU JAIN (Director)
Director ceased
PURNANDU SHEKHARMAL JAIN
12 Apr 2007
Charge satisfied
State Bank Of India
30 Sep 2006
Director appointed
ANUPAMA PURNANDU JAIN (Director)
28 Dec 2004
Charge created
State Bank Of India - 9.00 cr
23 Jan 2004
Charge created
State Bank Of India - 6.00 cr
Charge created
State Bank Of India - 4.00 cr
10
Key Observations
Auto-generated from the data above4 active director(s) / partner(s); review board churn before relying on management continuity.
All 3 registered charge(s) stand satisfied - past borrowings repaid.
Peer companies will appear here as our matching engine processes this industry.
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Aril Pharma Limited before audits and certifications: compliance score 23/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Aril Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Aril Pharma Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 49/100, distress signals and MSME payment-delay disclosures - know whether Aril Pharma Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Aril Pharma Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Aril Pharma Limited an active company?
Aril Pharma Limited has MCA status “Under Liquidation” with a compliance score of 23/100 (Caution Indicated).
Is Aril Pharma Limited financially healthy?
Processed financial statements are not yet available for Aril Pharma Limited, so its financial health is unassessed.
Should I do business with Aril Pharma Limited?
Its overall Trust Score is 49/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Aril Pharma Limited?
See the directors and ownership sections above for board and shareholding detail. 4 active director(s) are on record.
Does Aril Pharma Limited have loans or charges against its assets?
No open charges - all 3 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Aril Pharma Limited up to date with its ROC filings?
Last balance sheet is for Mar 2011 - filings overdue. Overall compliance score: 23/100 (Caution Indicated).
Is it risky to lend to Aril Pharma Limited?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
